SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000932440-08-000134
Filing Date
2008-02-14
Accepted
2008-02-14 13:46:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDED sched13g_1262580.htm SC 13G/A 204288
2 EXHIBIT 99.1 JOINT FILING AGREEMENT ex99-1_1262579.htm EX-99 27800
  Complete submission text file 0000932440-08-000134.txt   234322
Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Subject) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60307 | Film No.: 08612599
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022 212-624-2567
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A